journal article·2024-11-20Open access

Insight into Preventing Global Dengue Spread: Nanoengineered Niclosamide for Viral Infections

N. Sanoj Rejinold, Geun-woo Jin, Jin-Ho Choy

Nano Letters· Volume 24· Issue 46

Abstract

Millions of cases of dengue virus (DENV) infection yearly from Aedes mosquitoes stress the need for effective antivirals. No current drug effectively combats dengue efficiently. Transient immunity and severe risks highlight the need for broad-spectrum antivirals targeting all serotypes of DENV. Niclosamide, an antiparasitic, shows promising antiviral activity against the dengue virus, but enhancing its bioavailability is challenging. To overcome this issue and enable niclosamide to address the global dengue problem, nanoengineered niclosamides can be the solution. Not only does it address cost issues but also with its broad-spectrum antiviral effects nanoengineered niclosamide offers hope in addressing the current health crisis associated with DENV and will play a crucial role in combating other arboviruses as well.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Mosquito-borne diseases and control · HIV Research and Treatment · Studies on Chitinases and Chitosanases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Intelligent Nanohybrid Materials Laboratory (INML), College of Medicine, Dankook University, Cheonan 31116, Republic of Korea

Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 31116, Republic of Korea

R&D Center, Hyundai Bioscience Co. LTD., Seoul 03759, Republic of Korea

Division of Natural Sciences, The National Academy of Sciences, Seoul 06579, Republic of Korea

Tokyo Tech World Research Hub Initiative (WRHI), Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan

References (72)

Show source-provided references
1. 10.1186/s12889-024-19293-010.1186/s12889-024-19293-0 ↗
2. Thomas S. J. · 2023 · 1
3. 10.1186/s13071-023-05737-w10.1186/s13071-023-05737-w ↗
4. 10.1371/journal.pclm.000024010.1371/journal.pclm.0000240 ↗
5. 10.1155/2021/422481610.1155/2021/4224816 ↗
6. 10.4269/ajtmh.18-011710.4269/ajtmh.18-0117 ↗
7. 10.3390/tropicalmed805024110.3390/tropicalmed8050241 ↗
8. 10.1089/vbz.2023.010010.1089/vbz.2023.0100 ↗
9. Ahkami S. · Z. Tropenmed. Parasitol. · 1969 · 20 · 341
10. 10.1016/j.lana.2023.10067310.1016/j.lana.2023.100673 ↗
11. 10.1001/jama.2024.1035410.1001/jama.2024.10354 ↗
12. 10.1186/s12879-024-09580-x10.1186/s12879-024-09580-x ↗
13. 10.1080/22221751.2024.237331310.1080/22221751.2024.2373313 ↗
14. 10.1073/pnas.231208012110.1073/pnas.2312080121 ↗
15. 10.1038/s41598-024-65470-x10.1038/s41598-024-65470-x ↗
16. 10.1016/j.mjafi.2014.09.01110.1016/j.mjafi.2014.09.011 ↗
17. 10.1038/nri301410.1038/nri3014 ↗
18. 10.4269/ajtmh.14-013210.4269/ajtmh.14-0132 ↗
19. 10.3390/v212264910.3390/v2122649 ↗
20. 10.1371/journal.pcbi.101166210.1371/journal.pcbi.1011662 ↗
21. 10.1038/s41586-023-05790-610.1038/s41586-023-05790-6 ↗
22. 10.3390/v1503070510.3390/v15030705 ↗
23. 10.1038/nrmicro236810.1038/nrmicro2368 ↗
24. 10.1016/S0188-4409(02)00378-810.1016/S0188-4409(02)00378-8 ↗
25. 10.1186/s12967-020-02476-910.1186/s12967-020-02476-9 ↗
26. 10.1021/acsinfecdis.0c0005210.1021/acsinfecdis.0c00052 ↗
27. 10.1016/j.coviro.2012.02.01110.1016/j.coviro.2012.02.011 ↗
28. 10.1128/mbio.00706-2310.1128/mbio.00706-23 ↗
29. 10.1186/1743-422X-5-2710.1186/1743-422X-5-27 ↗
30. 10.1371/journal.pntd.000671510.1371/journal.pntd.0006715 ↗
31. 10.1038/s41598-019-45095-110.1038/s41598-019-45095-1 ↗
32. 10.3389/fimmu.2020.57803810.3389/fimmu.2020.578038 ↗
33. 10.1038/s41467-019-13659-410.1038/s41467-019-13659-4 ↗
34. 10.1186/s13071-021-05066-w10.1186/s13071-021-05066-w ↗
35. 10.1016/j.cmet.2014.01.00110.1016/j.cmet.2014.01.001 ↗
36. 10.1073/pnas.79.6.188910.1073/pnas.79.6.1889 ↗
37. 10.1124/dmd.119.08667810.1124/dmd.119.086678 ↗
38. 10.1001/jamainternmed.2022.683410.1001/jamainternmed.2022.6834 ↗
39. 10.1039/C7NR01973D10.1039/C7NR01973D ↗
40. 10.1080/21691401.2017.139699610.1080/21691401.2017.1396996 ↗
41. 10.33218/001c.1881310.33218/001c.18813 ↗
42. 10.1016/j.lfs.2020.11845810.1016/j.lfs.2020.118458 ↗
43. 10.1016/j.colsurfb.2021.11206310.1016/j.colsurfb.2021.112063 ↗
44. 10.1016/j.powtec.2022.11816810.1016/j.powtec.2022.118168 ↗
45. 10.1002/smll.20230514810.1002/smll.202305148 ↗
46. 10.18632/oncotarget.711310.18632/oncotarget.7113 ↗
47. 10.1038/s41467-019-13659-410.1038/s41467-019-13659-4 ↗
48. 10.3390/pharmaceutics1412256810.3390/pharmaceutics14122568 ↗
49. 10.1016/j.jare.2022.10.01810.1016/j.jare.2022.10.018 ↗
50. 10.1002/smll.20230514810.1002/smll.202305148 ↗
51. 10.1016/j.ijpharm.2021.12081910.1016/j.ijpharm.2021.120819 ↗
52. 10.1002/wnan.175410.1002/wnan.1754 ↗
53. 10.1038/nrd259110.1038/nrd2591 ↗
54. 10.1016/j.ejmech.2022.11412110.1016/j.ejmech.2022.114121 ↗
55. 10.1021/jp057170o10.1021/jp057170o ↗
56. 10.1002/elan.20040311310.1002/elan.200403113 ↗
57. 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
58. 10.1186/1477-3155-8-110.1186/1477-3155-8-1 ↗
59. 10.1126/science.109583310.1126/science.1095833 ↗
60. 10.1038/s41598-024-63239-w10.1038/s41598-024-63239-w ↗
61. 10.1038/s41598-021-85969-x10.1038/s41598-021-85969-x ↗
62. 10.1038/s41591-022-01945-610.1038/s41591-022-01945-6 ↗
63. 10.7150/thno.2385610.7150/thno.23856 ↗
64. 10.1007/978-3-030-44259-0_1010.1007/978-3-030-44259-0_10 ↗
65. 10.1021/acs.accounts.9b0036810.1021/acs.accounts.9b00368 ↗
66. 10.1021/acsabm.9b0059710.1021/acsabm.9b00597 ↗
67. 10.1016/j.antiviral.2022.10548810.1016/j.antiviral.2022.105488 ↗
68. 10.1039/D0NA00251H10.1039/D0NA00251H ↗
69. 10.1038/s41598-021-94172-x10.1038/s41598-021-94172-x ↗
70. 10.3390/bios1303034910.3390/bios13030349 ↗
71. World Health Organization. World Bank and WHO: Half the world lacks access to essential health services, 100 million still pushed into extreme poverty because of health expenses. Press Release, 2017, 13.
72. 10.1016/j.hgmx.2016.09.01110.1016/j.hgmx.2016.09.011 ↗